Researchers identify compound to prevent growth of Ebola virus

Advertisement
According to a recent study published, an experimental compound has been successfully used on rhesus monkeys in the initial trial phase by a team of US researchers. The compound has the ability to block the Ebola virus to replicate in the body- successfully preventing rhesus monkeys from succumbing to it.
These encouraging preclinical results suggest the compound, known as GS-5734, should be further developed as a potential treatment.
In animal studies, treatment initiated on day 3 post-infection with Ebola virus resulted in 100 percent survival of the monkeys. They also exhibited a substantial reduction in viral load and a marked decrease in the physical signs of disease, including internal bleeding and tissue damage.
Principal investigator Travis Warren of the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) said that the compound, which is a novel nucleotide analog prodrug, works by blocking the viral RNA replication process, adding "if the virus can't make copies of itself, the body's immune system has time to take over and fight off the infection."
These encouraging preclinical results suggest the compound, known as GS-5734, should be further developed as a potential treatment.
In animal studies, treatment initiated on day 3 post-infection with Ebola virus resulted in 100 percent survival of the monkeys. They also exhibited a substantial reduction in viral load and a marked decrease in the physical signs of disease, including internal bleeding and tissue damage.
Principal investigator Travis Warren of the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) said that the compound, which is a novel nucleotide analog prodrug, works by blocking the viral RNA replication process, adding "if the virus can't make copies of itself, the body's immune system has time to take over and fight off the infection."
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.